Functional characterization of adenosine receptors and coupling to ATP-sensitive K+ channels in Guinea pig urinary bladder smooth muscle.

Although multiple adenosine receptors have been identified, the subtype and underlying mechanisms involved in the relaxation response to adenosine in the urinary bladder remain unclear. The present study investigates changes in the membrane potential, as assessed by fluorescence-based techniques, of bladder smooth muscle cells by adenosine receptor agonists acting via ATP-sensitive potassium (K(ATP)) channels. Membrane hyperpolarization evoked by adenosine and various adenosine receptor subtype-selective agonists was attenuated or reversed by the K(ATP) channel blocker glyburide. Comparison of adenosine receptor agonist potencies eliciting membrane potential effects showed a rank order of potency 5'-N-ethyl-carboxamido adenosine (NECA; -log EC50 = 7.97) approximately 2-p-(2-carboxethyl)phenethyl-amino-5'-N-ethylcarboxamidoadenosine hydrochloride (CGS-21680; 7.65) > 2-chloro adenosine (5.90) approximately 2-chloro-N6-cyclopentyladenosine (CCPA; 5.51) approximately N6-cyclopentyladenosine approximately N6-(R)-phenylisopropyladenosine > 2-chloro- N6-(3-iodobenzyl)-adenosine-5'-N-methyl-carboxamide (2Cl-IBMECA; 4.78). Membrane potential responses were mimicked by forskolin, a known activator of adenylate cyclase, and papaverine, a phosphodiesterase inhibitor. The A(2A)-selective antagonist 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-yl-amino] ethyl)phenol (ZM-241385), and the adenylate cyclase inhibitor N-(cis-2-phenyl-cyclopentyl) azacyclotridecan-2-imine-hydrochloride (MDL-12330A) inhibited the observed change in membrane potential evoked by adenosine and adenosine-receptor agonists. The rank order potency for relaxation of K+-stimulated guinea pig bladder strips, NECA (-log EC50 = 6.41) approximately CGS-21680 (6.38) > 2-chloro adenosine (5.90) >> CCPA approximately 2Cl-IBMECA (>4.0) was comparable to that obtained from membrane potential measurements. Collectively, these studies demonstrate that adenosine-evoked membrane hyperpolarization and relaxation of bladder smooth muscle is mediated by A(2A) receptor-mediated activation of K(ATP) channels via adenylate cyclase and elevation of cAMP.

[1]  M. Gopalakrishnan,et al.  Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulators , 2002, British journal of pharmacology.

[2]  Sujatha M. Gopalakrishnan,et al.  Validation of FLIPR Membrane Potential Dye for High Throughput Screening of Potassium Channel Modulators , 2001, Journal of biomolecular screening.

[3]  H. Hikichi,et al.  Role of calcium channels and adenylate cyclase in the PACAP-induced adrenal catecholamine secretion. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  T. Hsiue,et al.  Mechanism of adenosine-induced vasodilation in rat diaphragm microcirculation. , 2000, American journal of physiology. Heart and circulatory physiology.

[5]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  M. Nelson,et al.  Regulation of urinary bladder smooth muscle contractions by ryanodine receptors and BK and SK channels. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  M. Williams,et al.  Purinergic and pyrimidinergic receptors as potential drug targets. , 2000, Biochemical pharmacology.

[8]  G. Spalluto,et al.  A3 Adenosine Receptor Ligands: History and Perspectives , 2000, Medicinal research reviews.

[9]  U. Sohn,et al.  The mechanism of contraction by 2-chloroadenosine in cat detrusor muscle cells. , 2000, The Journal of urology.

[10]  J. Bryan,et al.  Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. , 1999, Biochimica et biophysica acta.

[11]  R. Loutzenhiser,et al.  Afferent arteriolar adenosine A2a receptors are coupled to KATP in in vitro perfused hydronephrotic rat kidney. , 1999, American journal of physiology. Renal physiology.

[12]  N. Standen,et al.  Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A(1) and A(2) receptors in the pig coronary artery. , 1999, European journal of pharmacology.

[13]  T. Colatsky,et al.  Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat. , 1999, The Journal of pharmacology and experimental therapeutics.

[14]  J. Sullivan,et al.  Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. , 1999, The Journal of pharmacology and experimental therapeutics.

[15]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[16]  I Biaggioni,et al.  Adenosine A2B receptors. , 1997, Pharmacological reviews.

[17]  W. G. Staff,et al.  Purinergic modulation of rat urinary bladder detrusor smooth muscle. , 1997, General pharmacology.

[18]  N. Standen,et al.  ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. , 1997, Physiological reviews.

[19]  A. Gubitz,et al.  Tissue distribution of adenosine receptor mRNAs in the rat , 1996, British journal of pharmacology.

[20]  S. Hourani,et al.  Characterization of P1‐purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae , 1996, British journal of pharmacology.

[21]  M. Nelson,et al.  Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Jacobson,et al.  G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. , 1995, Molecular pharmacology.

[23]  P. Singh,et al.  The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist , 1995, British journal of pharmacology.

[24]  K. Jacobson,et al.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor. , 1994, Molecular pharmacology.

[25]  J. Daly,et al.  Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. , 1994, Biochemical pharmacology.

[26]  N. Standen,et al.  Adenosine‐activated potassium current in smooth muscle cells isolated from the pig coronary artery. , 1993, The Journal of physiology.

[27]  S. Hourani,et al.  Characterization of P1‐purinoceptors on rat duodenum and urinary bladder , 1992, British journal of pharmacology.

[28]  S. Rivkees,et al.  Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. , 1992, Molecular endocrinology.

[29]  M. Williams,et al.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. , 1992, Journal of medicinal chemistry.

[30]  G. Ghai,et al.  2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands. , 1990, Journal of medicinal chemistry.

[31]  A. Brading,et al.  Potassium channel blockers and the effects of cromakalim on the smooth muscle of the guinea‐pig bladder , 1990, British journal of pharmacology.

[32]  H. W. Hamilton,et al.  PD 116,948, a highly selective A1 adenosine receptor antagonist. , 1987, Life sciences.

[33]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[34]  K. Jacobson,et al.  P1 and P2 Purine and Pyrimidine Receptor Ligands , 2001 .

[35]  Maria P. Abbracchio,et al.  Molecular, nervous, and urogenitary system function , 2001 .

[36]  R. Levin,et al.  Normal detrusor is more sensitive than hypertrophied detrusor to in vitro ischemia followed by re‐oxygenation , 2000, Neurourology and urodynamics.

[37]  B. Fredholm,et al.  Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[38]  S. Seino.  ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. , 1999, Annual review of physiology.

[39]  K. Jacobson,et al.  A role for central A3-adenosine receptorsMediation of behavioral depressant effects , 1993 .